These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2226541)

  • 1. Reduction in hospital time to thrombolytic therapy by audit of policy guidelines.
    MacCallum AG; Stafford PJ; Jones C; Vincent R; Perez-Avila C; Chamberlain DA
    Eur Heart J; 1990 Aug; 11 Suppl F():48-52. PubMed ID: 2226541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delay times in the administration of thrombolytic therapy: the Brighton experience.
    More R; Moore K; Quinn E; Perez Avila C; Davidson C; Vincent R; Chamberlain D
    Int J Cardiol; 1995 Aug; 49 Suppl():S39-46. PubMed ID: 7591316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.
    Ketley D; Woods KL
    Br Heart J; 1995 Sep; 74(3):224-8. PubMed ID: 7547014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delays in thrombolytic therapy for acute myocardial infarction in Finland. Results of a national thrombolytic therapy delay study. Finnish Hospitals' Thrombolysis Survey Group.
    Hirvonen TP; Halinen MO; Kala RA; Olkinuora JT
    Eur Heart J; 1998 Jun; 19(6):885-92. PubMed ID: 9651712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prehospital thrombolytic therapy of acute myocardial infarct].
    Tebbe U; Carlsson J
    Herz; 1994 Dec; 19(6):303-13. PubMed ID: 7843687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis after acute myocardial infarction.
    Nee PA
    J Accid Emerg Med; 1997 Jan; 14(1):2-9. PubMed ID: 9023613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy in acute myocardial infarction.
    Paspa PA; Movahed A
    Am Fam Physician; 1992 Feb; 45(2):640-8. PubMed ID: 1739049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction.
    Brügemann J; van der Meer J; Takens BH; Hillege H; Lie KI
    Br Heart J; 1990 Dec; 64(6):355-8. PubMed ID: 2271340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival following thrombolytic therapy.
    Sleight P
    Eur Heart J; 1990 Aug; 11 Suppl F():1-4. PubMed ID: 2121486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary thrombolysis: still too little too late?
    Pinkney J; Catnach S; Woods A; Fairclough P
    Health Trends; 1993-1994; 25(4):132-4. PubMed ID: 10133874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project.
    Berger AK; Radford MJ; Krumholz HM
    Am Heart J; 2000 Jun; 139(6):985-92. PubMed ID: 10827378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?
    Handlin LR; Vacek JL
    Postgrad Med; 1994 Mar; 95(4):77-82. PubMed ID: 8121861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis in acute myocardial infarction.
    Holmberg SR
    Br J Hosp Med; 1992 Apr 15-May 5; 47(8):572-6, 578-80. PubMed ID: 1591557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term comparative study of anistreplase versus streptokinase in acute myocardial infarction.
    Silber H; Hausmann MJ; Katz A; Gilutz H; Zucker N; Ovsyshcher I
    Angiology; 1992 Jul; 43(7):572-7. PubMed ID: 1626735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the practicality and safety of thrombolysis with anistreplase given by general practitioners.
    Hannaford P; Vincent R; Ferry S; Hirsch S; Kay C
    Br J Gen Pract; 1995 Apr; 45(393):175-9. PubMed ID: 7612317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.
    Fears R; Ferres H; Glasgow E; Standring R; Hogg KJ; Gemmill JD; Burns JM; Rae AP; Dunn FG; Hillis WS
    Br Heart J; 1992 Aug; 68(2):167-70. PubMed ID: 1389731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prehospital thrombolysis with reteplase: the Nijmegen/Rotterdam study.
    Lamfers EJ; Schut A; Hooghoudt TE; Hertzberger DP; Boersma E; Simoons ML; Verheugt FW
    Am Heart J; 2003 Sep; 146(3):479-83. PubMed ID: 12947366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mortality from acute myocardial infarction in patients receiving anistreplase with those not receiving thrombolysis.
    Ozbek C; Heisel A; Krause M; Berg G; Hammer B; Bay W; Sen S; Schieffer H
    Am J Cardiol; 1995 Dec; 76(16):1103-7. PubMed ID: 7484891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Audit of prehospital thrombolysis by general practitioners in peripheral practices in Grampian.
    Rawles J; Sinclair C; Jennings K; Ritchie L; Waugh N
    Heart; 1998 Sep; 80(3):231-4. PubMed ID: 9875080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.